These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

948 related items for PubMed ID: 12395929

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Toll-like receptor signaling in anti-cancer immunity.
    Okamoto M, Sato M.
    J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
    [Abstract] [Full Text] [Related]

  • 6. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K.
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [Abstract] [Full Text] [Related]

  • 7. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
    Takesue Y, Ohge H, Kohyama M, Imamura Y, Murakami Y, Sueda T.
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):494-8. PubMed ID: 12884772
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential induction of gene promoter constructs by constitutively active human TLRs.
    Hasan UA, Dollet S, Vlach J.
    Biochem Biophys Res Commun; 2004 Aug 13; 321(1):124-31. PubMed ID: 15358224
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S.
    Science; 2003 Aug 01; 301(5633):640-3. PubMed ID: 12855817
    [Abstract] [Full Text] [Related]

  • 17. Critical roles of Toll-like receptors in host defense.
    Kaisho T, Akira S.
    Crit Rev Immunol; 2000 Aug 01; 20(5):393-405. PubMed ID: 11145217
    [Abstract] [Full Text] [Related]

  • 18. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.
    Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB.
    Immunity; 2007 May 01; 26(5):605-16. PubMed ID: 17462920
    [Abstract] [Full Text] [Related]

  • 19. Innate immunity: cells, receptors, and signaling pathways.
    Błach-Olszewska Z.
    Arch Immunol Ther Exp (Warsz); 2005 May 01; 53(3):245-53. PubMed ID: 15995585
    [Abstract] [Full Text] [Related]

  • 20. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity.
    Doyle SL, O'Neill LA.
    Biochem Pharmacol; 2006 Oct 30; 72(9):1102-13. PubMed ID: 16930560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.